Skip to main content

Sermorelin vs CJC-1295

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Sermorelin

Sermorelin is a synthetic analog of GHRH consisting of the first 29 amino acids of the natural hormone. It was previously FDA-approved for GH deficiency diagnosis and treatment in children.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Side-by-Side Comparison

AspectSermorelinCJC-1295
MechanismBinds to GHRH receptors in the pituitary gland to stimulate natural GH production and release. Maintains the body's natural feedback mechanisms for GH regulation.CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.
Typical DosageTypical dosing: 200-500mcg administered once daily, usually before bed. Some protocols use twice daily dosing.CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.
AdministrationSubcutaneous injection, preferably at bedtime to work with natural GH release patterns. Can be combined with GHRPs for synergistic effects.Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Side EffectsGenerally well-tolerated. May cause injection site reactions, headache, flushing, or dizziness. Less side effects than direct GH administration.Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Best For

What They Have in Common

Both Sermorelin and CJC-1295 are commonly used for:

Key Differences

Unique to Sermorelin:

Detailed Analysis

Both CJC-1295 and Sermorelin are commonly used for Muscle Growth, Fat Loss, Sleep Quality.

Which Should You Choose?

CJC-1295 has stronger evidence for Muscle Growth, Fat Loss.

Ready to Learn More?